Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TM02® in uncontrolled asthma
NCT06451328Phase 2Completed
- Sponsor
- Universiti Malaya
- Start
- Mar 2022
- Primary completion
- Feb 2023
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lignosus rhinocerus in asthma, sponsored by Universiti Malaya. Primary endpoints: Forced Expiratory Volume in 1 second at 90 days and Asthma Control Questionnaire-7 at 90 days. Started Mar 2022; status: completed.
02
Drugs
lignosus rhinocerus
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06451328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06451328.